Project Farma (PF)’s Post

A thought provoking read heading into 2024, as the industry predicts CGT and personalized medicine amongst the areas most likely to have great impact on pharma this year. I agree with the suggestion that there is a critical role for outsourcing in helping developers to navigate the unique challenges of these less established treatment modalities. https://lnkd.in/dB7Xar6Y   #Lonza #CGT #PersonalizedMedicine

Kite Pharma's Christopher McDonald discusses their recent #celltherapymanufacturing process change to #Yescarta that lowers Turnaround Time (TAT) from 16 to 14 days, the impact of available manufacturing capacity, and the potential for improved patient outcomes. #Apheresis #CARTcellTherapy #Tcells #Leukapheresis

Did you know that existing non-oncological drugs may hold the potential to improving glioblastoma treatment? 🧠🗝️💡 The team at ATCG is actively exploring the suitability of repurposed drug combinations for fighting this aggressive brain tumor. Repurposing involves finding new uses for approved drugs that are outside the scope of their original medical indication. This approach could potentially cut down the time and cost usually associated with the traditional drug development process 🔄🕰️. Artificial Intelligence is integrated into this process to create suprapersonalized drug combinations by using patented algorithms, aiming to enhance treatment efficacy and patient outcomes 🤖🧬💊. ATCG is aspiring to turn the tide against glioblastoma. Will you join as an investor? Please note: This information is for informational purposes only and should not replace advice from a healthcare provider. Always consult a qualified physician for advice on any medical condition. #glioblastomatreatment #drugrepurposing #braintumorresearch #revolutionizingmedicine #medicalinnovation #artificialintelligenceinhealthcare #personalizedmedicine #patientoutcomes #researchprogress #togetheragainstglioblastoma

Propulsion of Oral Mucositis Clinical Trial Pipeline as Novel and Extensive 10+ Therapies Likely to Enter in the Domain | DelveInsight: (Albany, United States) As per DelveInsight’s assessment, globally, the Oral Mucositis Pipeline constitutes 10+ key companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis … Continue reading → #HealthMedicine #PharmaceuticalsBiotech #Services

Propulsion of Oral Mucositis Clinical Trial Pipeline as Novel and Extensive 10+ Therapies Likely to Enter in the Domain | DelveInsight: (Albany, United States) As per DelveInsight’s assessment, globally, the Oral Mucositis Pipeline constitutes 10+ key companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis … Continue reading → #HealthMedicine #PharmaceuticalsBiotech #Services

Propulsion of Hepatorenal Syndrome Clinical Trial Pipeline as Novel and Extensive 3+ Therapies Likely to Enter in the Domain | DelveInsight: (Albany, United States) As per DelveInsight’s assessment, globally, the Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis … Continue reading → #HealthMedicine #PharmaceuticalsBiotech #Services

Propulsion of Hepatorenal Syndrome Clinical Trial Pipeline as Novel and Extensive 3+ Therapies Likely to Enter in the Domain | DelveInsight: (Albany, United States) As per DelveInsight’s assessment, globally, the Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis … Continue reading → #HealthMedicine #PharmaceuticalsBiotech #Services

Thoughts on this? >> A dozen early stage clinical trials to watch out for at AACR24 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #competitivemarketing

Thoughts on this? >> A dozen early stage clinical trials to watch out for at AACR24 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #healthcare #pharmaceutical #competitivemarketing

Move beyond your analytical boundaries. Tune in to industry experts as they discuss how they have been able to get more relevant information on in vitro transcribed (IVT) RNA and lipid nanoparticles (LNPs) for the next generation of therapeutics and vaccines. 👇 Watch on-demand now 👇 #mRNA #LipidNanoparticles #Vaccines #Biopharma #CapillaryElectrophoresis #MassSpectrometry